However, the dynamic and complex cellular networks within the TME could enhance the development of tumour resistance mechanisms, such as overexpressing PD-L1, a counterpart of PD-1, which enable cancer cells to escape immune elimination. The gene discussed is CD274; the disease is neoplasm.